Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Prostaglandin H2

From Wikipedia, the free encyclopedia
Prostaglandin H2[1]
Names
Other names
PGH2, Endoperoxide H2, Prostaglandin R2
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
MeSHProstaglandin+H2
UNII
  • InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 checkY
    Key: YIBNHAJFJUQSRA-YNNPMVKQSA-N checkY
  • InChI=1/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1
    Key: YIBNHAJFJUQSRA-YNNPMVKQBN
  • O=C(O)CCC/C=C\C[C@H]2[C@H]1OO[C@H](C1)[C@@H]2/C=C/[C@@H](O)CCCCC
Properties
C20H32O5
Molar mass352.465 g/mol
Density1.129 ± 0.06 g/mL
Boiling point490 ± 40.0 °C
0.034 g/L
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

Prostaglandin H2 (PGH2), orprostaglandin H2 (PGH2), is a type ofprostaglandin and a precursor for many other biologically significant molecules. It is synthesized fromarachidonic acid in a reaction catalyzed by acyclooxygenase enzyme.[2] The conversion fromarachidonic acid to prostaglandin H2 is a two-step process. First,COX-1 catalyzes the addition of two free oxygens to form the1,2-dioxane bridge and a peroxide functional group to formprostaglandin G2 (PGG2).[3] Second,COX-2 reduces the peroxide functional group to asecondary alcohol, forming prostaglandin H2. Other peroxidases likehydroquinone have been observed to reduce PGG2 to PGH2.[4] PGH2 is unstable at room temperature, with a half life of 90–100 seconds,[1] so it is often converted into a different prostaglandin. PGH2 is produced by every type of cell except for red blood cells and has a wide range of effects in the body.[5]

Eicosanoid synthesis – prostaglandin H2 near center

It is acted upon by:

It rearranges non-enzymatically to:

Functions of prostaglandin H2:

  • regulating the constriction and dilation of blood vessels
  • stimulating platelet aggregation
    • binds tothromboxane receptor on platelets' cell membranes to trigger platelet migration and adhesion to other platelets[8]

Effects ofaspirin on prostaglandin H2:

  • Aspirin has been hypothesized to block the conversion of arachidonic acid to prostaglandin
Figure 1: Synthetic pathways from PGH2 (the parent compound) to prostaglandins, prostacyclin and thromboxanes

History

[edit]

Prostaglandin H2 was discovered in 1973 by Diederik H. Nugteren and Elly Christ-Hazelhof while they were researching the formation of prostaglandin E2 from arachidonic acid using enzymes found invesicular glands.[9]

Synthesis

[edit]

The original synthesis of prostaglandin H2 by Diederik H. Nugteren and Elly Christ-Hazelhof was performed in 1973.[9] Sheep vesicular glands were homogenized with 1MKH2PO4 and 0.001 MEDTA buffer and then centrifuged to isolate the COX-1 enzymes. Pure arachidonic acid was added to a solution containing the enzymes, and the mixture was shaken.Thin-layer chromatography was used to isolate a band of prostaglandin H2.

In 1986, due to low prostaglandin H2 product purity from thin-layer chromatography and columnchromatography,high-performance liquid chromatography withhexane andisopropanol as solvents was developed as an alternative means of isolating the prostaglandin with 98% purity.[10]

References

[edit]
  1. ^abWishart, David S.; Guo, An Chi; Oler, Eponine; Wang, Fel; Anjum, Afia; Peters, Harrison; Dizon, Raynard; Sayeeda, Zinat; Tian, Siyang; Lee, Brian L.; Berjanskii, Mark; Mah, Robert; Yamamoto, Mai; Jovel Castillo, Juan; Torres Calzada, Claudia; Hiebert Giesbrecht, Mickel; Lui, Vicki W.; Varshavi, Dorna; Varshavi, Dorsa; Allen, Dana; Arndt, David; Khetarpal, Nitya; Sivakumaran, Aadhavya; Harford, Karxena; Sanford, Selena; Yee, Kristen; Cao, Xuan; Budinsky, Zachary; Liigand, Jaanus; Zhang, Lun; Zheng, Jiamin; Mandal, Rupasri; Karu, Naama; Dambrova, Maija; Schiöth, Helgi B.; Gautam, Vasuk."Showing metabocard for Prostaglandin H2 (HMDB0001381)".Human Metabolome Database, HMDB. 5.0.
  2. ^van der Donk WA, Tsai AL, Kulmacz RJ (December 2002). "The cyclooxygenase reaction mechanism".Biochemistry.41 (52):15451–8.doi:10.1021/bi026938h.PMID 12501173.
  3. ^Salomon RG, Miller DB, Zagorski MG, Coughlin DJ (October 1984). "Prostaglandin endoperoxides. 14. Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution".Journal of the American Chemical Society.106 (20):6049–6060.doi:10.1021/ja00332a049.ISSN 0002-7863.
  4. ^Hla T, Neilson K (August 1992)."Human cyclooxygenase-2 cDNA".Proceedings of the National Academy of Sciences of the United States of America.89 (16):7384–8.Bibcode:1992PNAS...89.7384H.doi:10.1073/pnas.89.16.7384.PMC 49714.PMID 1380156.
  5. ^Miller, Stephen B. (2006-08-01)."Prostaglandins in Health and Disease: An Overview".Seminars in Arthritis and Rheumatism.36 (1):37–49.doi:10.1016/j.semarthrit.2006.03.005.ISSN 0049-0172.
  6. ^Hirata, Takako; Narumiya, Shuh (2011-08-05)."Prostanoid Receptors".ACS Publications.doi:10.1021/cr200010h. Retrieved2025-11-16.
  7. ^Boutaud, Olivier; Ou, Joyce J.; Chaurand, Pierre; Caprioli, Richard M.; Montine, Thomas J.; Oates, John A. (2002)."Prostaglandin H2 (PGH2) accelerates formation of amyloid β1−42 oligomers".Journal of Neurochemistry.82 (4):1003–1006.doi:10.1046/j.1471-4159.2002.01064.x.ISSN 1471-4159.
  8. ^Woodward DF, Jones RL, Narumiya S (September 2011)."International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress".Pharmacological Reviews.63 (3):471–538.doi:10.1124/pr.110.003517.PMID 21752876.
  9. ^abNugteren, D. H.; Hazelhof, E. (1973-12-20)."Isolation and properties of intermediates in prostaglandin biosynthesis".Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism.326 (3):448–461.doi:10.1016/0005-2760(73)90145-8.ISSN 0005-2760.
  10. ^Zulak, I. M.; Puttemans, M. L.; Schilling, A. B.; Hall, E. R.; Venton, D. L. (1986-04-01)."A fast, nondestructive purification scheme for prostaglandin H2 using a nonaqueous, bonded-phase high-performance liquid chromatography system".Analytical Biochemistry.154 (1):152–161.doi:10.1016/0003-2697(86)90509-9.ISSN 0003-2697.
Precursor
Prostanoids
Prostaglandins (PG)
Precursor
Active
D/J
E/F
I
Thromboxanes (TX)
Leukotrienes (LT)
Precursor
Initial
SRS-A
Eoxins (EX)
Precursor
Eoxins
Nonclassic
By function
Receptor
(ligands)
DP (D2)Tooltip Prostaglandin D2 receptor
DP1Tooltip Prostaglandin D2 receptor 1
DP2Tooltip Prostaglandin D2 receptor 2
EP (E2)Tooltip Prostaglandin E2 receptor
EP1Tooltip Prostaglandin EP1 receptor
EP2Tooltip Prostaglandin EP2 receptor
EP3Tooltip Prostaglandin EP3 receptor
EP4Tooltip Prostaglandin EP4 receptor
Unsorted
FP (F)Tooltip Prostaglandin F receptor
IP (I2)Tooltip Prostacyclin receptor
TP (TXA2)Tooltip Thromboxane receptor
Unsorted
Enzyme
(inhibitors)
COX
(
PTGS)
PGD2STooltip Prostaglandin D synthase
PGESTooltip Prostaglandin E synthase
PGFSTooltip Prostaglandin F synthase
PGI2STooltip Prostacyclin synthase
TXASTooltip Thromboxane A synthase
Others
Stub icon

Thisbiochemistry article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Prostaglandin_H2&oldid=1322561701"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp